Colorectal Cancer Archive

A 2025 study that included 97,000 people found that those who ate the most cruciferous vegetables—between 20 and 40 grams per day—had a 17% lower risk of developing colon cancer, compared with people who ate the least.

A 2025 research review found that adhering to the DASH diet—which emphasizes eating fruits, vegetables, lean protein, whole grains, nuts, and low-fat dairy products—is linked to a lower risk of developing colorectal cancer.

In a 2025 study of about 900 people treated for colon cancer (followed for an average of eight years), people who took part in a supervised exercise program for three years had about 30% better odds of surviving, compared with people who weren’t in the program.

A 2025 study suggested that boosting dietary calcium intake may reduce the odds of developing colorectal cancer, while drinking more alcohol may raise risks for the disease.

In 2024, the FDA approved a blood test called Shield as a screening method for colorectal cancer. The test detects 83% of colorectal cancers, but only 13% of precancerous polyps. The FDA approval means that now many insurance plans will pay for the test.

Of the cancer screening tests for men, tests for colon cancer has the strongest evidence for benefit. Men who opt in for prostate cancer screening may have more options beyond PSA blood testing to more accurately identify aggressive cancers. Other screening tests such as full body scans have not been shown to improve outcomes.

Screening methods for colorectal cancer continue to evolve. Stool tests are becoming more accurate, and it appears that an experimental blood test might one day provide another effective screening option. The most accurate colorectal cancer screening is a colonoscopy, which allows a doctor to peer inside the colon and rectum, find cancers, and remove potentially precancerous polyps on the spot to prevent future cancer. It's unclear if a stool or blood test will ever be as good for screening as a colonoscopy.

A 2023 study suggests that having diabetes may be tied to a higher risk of developing colorectal cancer than not having diabetes.

Lynch syndrome is an inherited condition that predisposes people to colorectal, uterine, ovarian, and other forms of cancer. Genetic testing can pinpoint Lynch syndrome, and genetic counseling is also recommended. People with Lynch syndrome need frequent cancer screenings and should watch for symptoms. Women with Lynch syndrome are also advised to undergo risk-reducing surgery that removes the ovaries, fallopian tubes, and uterus between ages 35 and 40, unless a woman is planning another pregnancy.